Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-Year final clinical outcomes from the MASCOT post-marketing registry
- 21 January 2019
- journal article
- research article
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 283, 67-72
- https://doi.org/10.1016/j.ijcard.2019.01.053
Abstract
No abstract availableKeywords
Funding Information
- OrbusNeich Medical
This publication has 34 references indexed in Scilit:
- Capture of circulatory endothelial progenitor cells and accelerated re-endothelialization of a bio-engineered stent in human ex vivo shunt and rabbit denudation modelEuropean Heart Journal, 2011
- Standardized Bleeding Definitions for Cardiovascular Clinical TrialsCirculation, 2011
- Trends in Coronary Revascularization in the United States From 2001 to 2009Circulation: Cardiovascular Quality and Outcomes, 2011
- Stent ThrombosisJournal of the American College of Cardiology, 2010
- Coronary Stents: Looking ForwardJournal of the American College of Cardiology, 2010
- Coronary Stents: Current StatusJournal of the American College of Cardiology, 2010
- Development of a Novel Prohealing Stent Designed to Deliver Sirolimus From a Biodegradable Abluminal MatrixCirculation: Cardiovascular Interventions, 2010
- Genous™ endothelial progenitor cell capturing stent vs. the Taxus Liberté stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot studyEuropean Heart Journal, 2009
- Clinical End Points in Coronary Stent TrialsCirculation, 2007
- Late Stent ThrombosisCirculation, 2007